企業プロフィール
Evogene 株価・ニュース・カタリスト
- ティッカー:
- EVGN
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- Israel
株価パフォーマンス
0.56 USD (-6.79%)
終値
最終更新: 2026年8月17日
6.14M USD
時価総額
株価変動の要因
As of Aug 17, 2026, EVGN closed down 6.79% at $0.5600. No new same-company headline was identified in the current news window.
企業概要
事業概要
Evogene is a computational biology and platform company focused on using data science to design biological products across agriculture and life sciences. Its business is more about biological engineering than drug development.
所在地とセクター分類
Evogene is headquartered in Israel and listed on NASDAQ. It sits in biotechnology tools and computational biology.
ビジネスモデルの特徴
The company depends on platform adoption, strategic partnerships, and the ability to monetize computational biology across multiple end markets. Investors watch collaborations, platform breadth, and commercial execution.
バイオ業界での位置付け
Evogene occupies a platform-biology niche rather than a classic therapeutics role. It matters to the broader biotech ecosystem because it enables biological design and discovery.
今後のカタリスト
- Evogene’s catalysts are platform execution across ag-biotech and pharma discovery, plus any update that shows its computational biology approach can keep producing value. The market will watch whether the platform remains relevant.
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。